ADC Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes

LAUSANNE, Switzerland, June 27, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that the Company is set to join the Russell 2000® Index and the broad-market Russell 3000® Index at the conclusion of the 2024 Russell US Indexes annual reconstitution, effective at the open of US equity markets on Monday, July 1, 2024. “We are pleased to be joining the Russell 2000® Index,” said Ameet Mallik, Chief Executive Officer of ADC Therapeutics. “This is a significant benchmark validating the f ...